Table 3 Intensive care characteristics and complications of patients admitted to ICU post PPCI. Results are expressed as mean (SD) unless otherwise denoted
| Â | All patients | Outcome | Indication for ICU | ||||||
|---|---|---|---|---|---|---|---|---|---|
Survivor | Non-survivor | Sign | OHCA | IHCA | Card shock | Pulm edema | Sign | ||
Total number of patients (%) | 101 (100) | 67 (66.3) | 34 (33.7) | Â | 37 (36.6) | 32 (31.7) | 23 (22.8) | 9 (8.9) | Â |
ICU interventions | |||||||||
 Invasive mechanical ventilation, no (%) | 87 (86.1) | 56 (55.5) | 31 (30.7) | 0.373 | 37 (36.6) | 31 (30.7) | 12 (11.9) | 7 (6.9) | < 0.001 |
  Duration of IMV, median days (IQR) | 2 (1–3) | 2 (1–2) | 2 (1–6) | 0.314 | 2 (2–4) | 1 (1–2) | 2 (1–5) | 1 (1–1) | 0.011 |
 Non-invasive ventilation, no (%) | 25 (24.8) | 21 (20.8) | 4 (4.0) | 0.049 | 7 (6.9) | 5 (5.0) | 8 (7.9) | 5 (5.0) | 0.047 |
  Duration of NIV, median days (IQR) | 1 (1–2) | 1 (1–2) | 2.5 (1.5–3) | 0.075 | 1 (1–1) | 2 (1–2) | 2 (1.5–3) | 1 (1–1) | 0.032 |
 Inotropes, median number (IQR) | 1 (0–1) | 0 (0–1) | 1 (0–2) | 0.005 | 1 (0–1) | 1 (0–2) | 0 (0–1) | 0 (0–1) | 0.617 |
 Vasopressors, median number (IQR) | 0 (0–1) | 0 (0–1) | 1 (0–1) | 0.001 | 0 (0–1) | 0 (0–1) | 0 (0–1) | 0 (0–1) | 0.971 |
 ECMO, no (%) | 7 (6.9) | 1 (1.0) | 6 (5.9) | 0.006 | 0 (0.0) | 7 (6.9) | 0 (0.0) | 0 (0.0) | 0.001 |
 Therapeutic hypothermia, no (%) | 48 (47.5) | 33 (32.7) | 15 (14.9) | 0.677 | 32 (31.7) | 14 (13.9) | 0 (0.0) | 2 (2.0) | < 0.001 |
 IABP, no (%) | 59 (58.4) | 35 (34.7) | 24 (23.8) | 0.090 | 15 (14.9) | 23 (22.8) | 18 (17.8) | 3 (3.0) | 0.004 |
 Renal repl therapy, no (%) | 27 (26.7) | 10 (9.9) | 17 (16.8) | < 0.001 | 6 (5.9) | 11 (10.9) | 8 (7.9) | 2 (2.0) | 0.273 |
In-hospital complications | |||||||||
 Major bleeding, no (%) | 10 (9.9) | 6 (5.9) | 4 (4.0) | 0.082 | 0 (0.0) | 7 (6.9) | 2 (2.0) | 1 (1.0) | 0.026 |
 Infections, no (%) | 32 (31.7) | 21 (20.8) | 11 (10.9) | 1.000 | 13 (12.9) | 9 (8.9) | 7 (6.9) | 3 (3.0) | 0.936 |
 Renal dysfunction (new onset), no (%) | 34 (33.7) | 18 (17.8) | 16 (15.8) | 0.048 | 12 (11.9) | 11 (10.9) | 9 (8.9) | 2 (2.0) | 0.833 |
 In ICU Cardiopulmonary arrest, no (%) | 7 (6.9) | 0 (0.0) | 7 (6.9) | < 0.001 | 3 (3.0) | 4 (4.0) | 0 (0.0) | 0 (0.0) | 0.261 |
Outcomes | |||||||||
 Duration of ICU stay, median days (IQR) | 3 (1–5) | 3 (1–4) | 2 (0.5–7) | 0.389 | 3 (2–7) | 2 (1–5) | 3 (0.5–5) | 1 (0.5–2) | 0.095 |
 ICU mortality, no (%) | 34 (33.7) |  |  |  | 11 (10.9) | 13 (12.9) | 9 (8.9) | 1 (1.0) | 0.346 |
 Hospital / 28-day mortality, no (%) | 37 (36.6) |  |  |  | 12 (11.9) | 14 (13.9) | 10 (9.9) | 1 (1.0) | 0.265 |
Cause of death (of 37 patients) | |||||||||
 Treatment withdrawn, no (%) | 25 (67.6) |  |  |  | 7 (18.9) | 9 (24.3) | 8 (21.6) | 1 (2.7) | 0.632 |
 Cardiac Arrest, no (%) | 7 (18.9) |  |  |  | 3 (8.1) | 2 (5.4) | 2 (5.4) | 0 (0.0) | 0.867 |
 Other | 5 (13.5) |  |  |  | 2 (5.4) | 3 (8.1) | 0 (0.0) | 0 (0.0) | 0.463 |